Aseptic Compounding for DHBs (chemotherapy, antibiotics and misc. compounding)

Details

Tender Closed
RFx ID :	23479015
Tender Name :	Aseptic Compounding for DHBs (chemotherapy, antibiotics and misc. compounding)
Reference # :	30275
Open Date :	Thursday, 22 October 2020 2:00 PM (Pacific/Auckland UTC+13:00)
Close Date  :	Monday, 30 November 2020 10:00 AM (Pacific/Auckland UTC+13:00)
Department/Business Unit :	Procurement
Tender Type :	Request for Proposals (RFP)
Tender Coverage :	Syndicated Opportunity  [?]
Categories :	51000000 - Drugs and Pharmaceutical Products 73101700 - Pharmaceutical production
Regions:	Auckland Bay of Plenty Canterbury Chatham Islands Gisborne Hawke's Bay Manawatu-Wanganui Marlborough Nelson Northland Otago Southland Taranaki Tasman Waikato Wellington West Coast
Exemption Reason :	None
Required Pre-qualifications :	None
Contact :	Abhijit Trikannad abhijit.trikannad@nzhealthpartnerships.co.nz 021961031
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :
Agency Address :	NEW ZEALAND

District Health Boards (DHBs) have a requirement for aseptically compounded pharmaceutical products and services (Aseptic Compounding) for a wide range of uses.

Aseptic Compounding refers to the handling and processing of sterile ingredients to create an end product that remains sterile. Such processing is often required when a high degree of dose customisation is required, no commercial alternatives are available or an immediate pharmacological effect is required.

The Aseptic Compounding process requires clean room environments with cabinets/isolators that are consistently monitored for air flow, humidity, pressure changes, temperature and contamination.

While some DHBs have in house compounding units, sterile products may also be sourced from:
• Private suppliers of aseptically compounded products
• Aseptic compounding units of other DHBs

As at the time of writing, the national contract for Aseptic Compounding is set to expire in January 2021. This presents an opportunity for NZ Health Partnerships to promote competitiveness, encouraging new supplier participation and exploring alternative solutions for Aseptic Compounding.

This tender has been awarded. Total spend value $ 125,000,000.

• BIOMED LIMITED - 52, Carrington Road, Point Chevalier, Auckland, 1025, NEW ZEALAND
• Baxter Healthcare Limited - 1, Baxter Drive, Old Toongabbie, NSW, 2146, AUSTRALIA
• iMIX Ltd - 1E, Austin St, Ahuriri, Napier, Hawkes Bay, 4110, NEW ZEALAND

Further Award Information:
Agency: New Zealand Health Partnerships Limited
Floor 1, Building 7, 660 670 Great South Road, Penrose, Auckland, 1061 , New Zealand

New Zealand Health Partnerships Limited has appointed Baxter Healthcare Limited and Imix Limited to the Aseptically Compounded Pharmaceutical Products and Services Panel (The Panel) following an RFP.

Baxter Healthcare Limited NZBN 9429040404080
Baxter Healthcare Limited, 33 Vestey Drive, Auckland, 1060 , New Zealand
Term: 1 July 2021 - 20 June 2026

Imix Limited NZBN 9429046731388
Bizdom Limited, Level 1, 3 Byron Street, Napier, 4112 , New Zealand
Term: 21 June 2021 - 20 June 2026

Biomed Limited NZBN 9429000105088 Biomed Ltd, 52 Carrington Road, Point Chevalier, Auckland, 1025 , New Zealand
Term: 1 February 2022 - 20 June 2026


The Panel provides outsourced services to District Health Boards for compounding chemotherapy, antibiotics and miscellaneous medicines (analgesics and IV additives). It excludes nutrition compounding.

The total addressable spend over the five year term of the ACPPS Panel is $125m.

Award Date: Monday, 2 August 2021 (Pacific/Auckland UTC+12:00)
Date RFx was completed/updated: Friday, 25 February 2022 9:32 AM (Pacific/Auckland UTC+13:00)